Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation
- PMID: 2170285
Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation
Abstract
The anti-inflammatory drug nimesulide was found to effectively reduce the availability of hypochlorous acid, the most potent chlorinated oxidant generated by the myeloperoxidase system of activated neutrophils. Such an effect was observed at concentrations achievable in vivo after the oral administration of the drug. Higher concentrations of nimesulide were also found to limit both the oxygen consumption and the superoxide anion/hydrogen peroxide production by neutrophils. Taken together, the results suggest that nimesulide is endowed with a high potential to efficiently control the harmful effects of oxidants produced by neutrophils at inflammatory tissue sites.
Similar articles
-
Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes.Drugs. 1993;46 Suppl 1:29-33. doi: 10.2165/00003495-199300461-00007. Drugs. 1993. PMID: 7506191 Review.
-
Neutrophil- and myeloperoxidase-mediated metabolism of reduced nimesulide: evidence for bioactivation.Chem Res Toxicol. 2010 Nov 15;23(11):1691-700. doi: 10.1021/tx1001496. Epub 2010 Oct 12. Chem Res Toxicol. 2010. PMID: 20939553
-
Inhibition of the neutrophil oxidative response induced by the oral administration of nimesulide in normal volunteers.J Clin Lab Immunol. 1992;37(2):91-6. J Clin Lab Immunol. 1992. PMID: 1340506
-
Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione.Biochem J. 2009 Dec 14;425(1):285-93. doi: 10.1042/BJ20090776. Biochem J. 2009. PMID: 19828014
-
Possible modes of action of nimesulide in controlling neutrophilic inflammation.Arzneimittelforschung. 1995 Oct;45(10):1114-7. Arzneimittelforschung. 1995. PMID: 8595071 Review.
Cited by
-
Nimesulide. New clinical opportunities.Drugs. 1993;46 Suppl 1:275-6. doi: 10.2165/00003495-199300461-00069. Drugs. 1993. PMID: 7506189 No abstract available.
-
Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils.Drugs. 1993;46 Suppl 1:52-8. doi: 10.2165/00003495-199300461-00011. Drugs. 1993. PMID: 7506195
-
Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1994 Sep;48(3):431-54. doi: 10.2165/00003495-199448030-00009. Drugs. 1994. PMID: 7527762 Review.
-
Antioxidant activity of nimesulide and its main metabolites.Drugs. 1993;46 Suppl 1:15-21. doi: 10.2165/00003495-199300461-00005. Drugs. 1993. PMID: 7506157
-
Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes.Drugs. 1993;46 Suppl 1:29-33. doi: 10.2165/00003495-199300461-00007. Drugs. 1993. PMID: 7506191 Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials